172 related articles for article (PubMed ID: 2172501)
1. Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
Pizzo PA; Butler K; Balis F; Brouwers E; Hawkins M; Eddy J; Einloth M; Falloon J; Husson R; Jarosinski P
J Pediatr; 1990 Nov; 117(5):799-808. PubMed ID: 2172501
[TBL] [Abstract][Full Text] [Related]
2. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
[TBL] [Abstract][Full Text] [Related]
3. Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
Skowron G; Merigan TC
Am J Med; 1990 May; 88(5B):20S-23S. PubMed ID: 2159705
[TBL] [Abstract][Full Text] [Related]
4. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
Yarchoan R; Perno CF; Thomas RV; Klecker RW; Allain JP; Wills RJ; McAtee N; Fischl MA; Dubinsky R; McNeely MC
Lancet; 1988 Jan; 1(8577):76-81. PubMed ID: 2891981
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
Meng TC; Fischl MA; Boota AM; Spector SA; Bennett D; Bassiakos Y; Lai SH; Wright B; Richman DD
Ann Intern Med; 1992 Jan; 116(1):13-20. PubMed ID: 1345755
[TBL] [Abstract][Full Text] [Related]
6. [Sequential dideoxycytidine and zidovudine in advanced HIV-1 infection. Phase II study].
Ruiz-Argüelles GJ; Lagunes-Yannelli B; Mercado-Díaz L
Rev Invest Clin; 1993; 45(2):145-7. PubMed ID: 8393211
[TBL] [Abstract][Full Text] [Related]
7. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
Whitfield RM; Bechtel LM; Starich GH
Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
[TBL] [Abstract][Full Text] [Related]
8. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
Meng TC; Fischl MA; Richman DD
Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
[TBL] [Abstract][Full Text] [Related]
9. Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model.
Basham T; Holdener T; Merigan T
J Infect Dis; 1991 Apr; 163(4):869-72. PubMed ID: 1849164
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
Kaulen P; Pham DT; Baranowski E; Wollensak J
Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
[TBL] [Abstract][Full Text] [Related]
11. Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine.
Bozzette SA; Richman DD
Am J Med; 1990 May; 88(5B):24S-26S. PubMed ID: 2159706
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
Spector SA; Ripley D; Hsia K
Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
[TBL] [Abstract][Full Text] [Related]
13. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee.
Lancet; 1996 Aug; 348(9023):283-91. PubMed ID: 8709686
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
[TBL] [Abstract][Full Text] [Related]
15. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
Shirasaka T; Yarchoan R; O'Brien MC; Husson RN; Anderson BD; Kojima E; Shimada T; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):562-6. PubMed ID: 8380641
[TBL] [Abstract][Full Text] [Related]
16. Treatment of AIDS with combinations of antiretroviral agents.
Merigan TC
Am J Med; 1991 Apr; 90(4A):8S-17S. PubMed ID: 1850192
[TBL] [Abstract][Full Text] [Related]
17. Dideoxycytidine: current clinical experience and future prospects. A summary.
Broder S; Yarchoan R
Am J Med; 1990 May; 88(5B):31S-33S. PubMed ID: 2159708
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine and dideoxycytidine differ in their effects on human immunodeficiency virus-induced pathologic activation of the immune system. AIDS Clinical Trial Research Group 047.
Liu M; Fahey JL; Aziz N; Cumberland WG; Skowron G; Merigan T
J Infect Dis; 1994 Nov; 170(5):1165-71. PubMed ID: 7963709
[TBL] [Abstract][Full Text] [Related]
19. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.
Mueller BU; Jacobsen F; Butler KM; Husson RN; Lewis LL; Pizzo PA
J Pediatr; 1992 Nov; 121(5 Pt 1):797-802. PubMed ID: 1279153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
